Status:
COMPLETED
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether ecabet ophthalmic solution is an effective treatment for dry eye syndrome
Eligibility Criteria
Inclusion
- Male/female at least 18 years of age
- Agree to avoid disallowed medications
- Have a diagnosis of dry eye
Exclusion
- Have chronic systemic inflammation
- Have active seasonal ocular allergies
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
End Date :
June 1 2007
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT00370747
Start Date
September 1 2006
End Date
June 1 2007
Last Update
March 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irvine, California, United States, 92618